跳到主要导航 跳到搜索 跳到主要内容

Genomic surveillance of H1N1, H3N2 and influenza B Victoria lineage viruses in Qingyang (2020–2023): phylogenetic and molecular characteristics analysis of HA/NA genes

  • Guina Zhu
  • , Huaizhe Hou
  • , Wenjun Wang
  • , Zhihui Dou
  • , Yanhong Ji
  • Xi'an Jiaotong University
  • Qingyang Center for Disease Control and Prevention
  • Qingyang People’s Hospital
  • Gansu Preventive Medicine Association
  • Chinese Center for Disease Control and Prevention

科研成果: 期刊稿件文章同行评审

1 引用 (Scopus)

摘要

Background: HA and NA are important surface proteins of influenza viruses. The purpose of this study was to explore the molecular evolution and amino acid mutations of HA and NA of H1N1, H3N2 and Influenza B Victoria lineage (B/Victoria) viruses in Qingyang from 2020 to 2023. Methods: Through the China Influenza Surveillance Information System, the positive data of influenza etiology surveillance in Qingyang from 2020 to 2023 were screened. A total of 19 samples of H1N1, 47 samples of H3N2 and 51 samples of B/Victoria were screened. Subsequently, virus nucleic acid extraction, whole genome sequencing, amino acid and nucleotide homology analysis, phylogenetic analysis, and amino acid site mutation analysis were performed. Results: Miniseq sequencing was performed on 117 influenza strains. Homology analysis showed that H1N1 and H3N2 strains had relatively low homology with vaccine representative strains. Amino acid mutation analysis of HA and NA showed that the H1N1 strains had receptor binding site and antigen site mutations, but no glycosylation site and resistance site mutations. However, H3N2 strains had mutations at receptor binding sites, antigenic sites, glycosylation sites, and resistance sites. The B/Victoria strains had antigenic site mutations, but no drug resistance site mutations. Moreover, only strains from 2021 to 2022 exhibit a glycosylation site mutation. Conclusion: Genetic characteristics analysis was conducted for the first time on H1N1, H3N2, and B/Victoria viruses prevalent in Qingyang, which enables us to understand the molecular evolution and amino acid mutations of HA and NA. Clinical trial number: Not applicable.

源语言英语
期刊论文编号678
期刊BMC Infectious Diseases
26
1
DOI
出版状态已出版 - 12月 2026

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Genomic surveillance of H1N1, H3N2 and influenza B Victoria lineage viruses in Qingyang (2020–2023): phylogenetic and molecular characteristics analysis of HA/NA genes' 的科研主题。它们共同构成独一无二的学术指纹。

引用此